HHLA2 Expression is Associated with Poor Survival in Patients with Hepatocellular Carcinoma
Yituo Xu,1 Zhijie Huang,1 Xingjuan Yu,1 Zhixiong Li,1 Limin Zheng,1,2 Jing Xu1 1Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou, 510060, People’s Republic of China; 2MOE Key Laboratory of...
Guardado en:
Autores principales: | Xu Y, Zhijie H, Yu X, Li Z, Zheng L, Xu J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d6ba58db404467da628f464ba4bf014 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment
por: Luo M, et al.
Publicado: (2021) -
Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
por: Luo M, et al.
Publicado: (2021) -
Expression and clinical significance of CMTM1 in hepatocellular carcinoma
por: Song Xin, et al.
Publicado: (2021) -
Identification and clinical validation of EMT-associated prognostic features based on hepatocellular carcinoma
por: Dafeng Xu, et al.
Publicado: (2021) -
Elevated Serum Uric Acid is Associated With Poor Survival in Advanced HCC Patients and Febuxostat Improves Prognosis in HCC Rats
por: Le Wu, et al.
Publicado: (2021)